tumor biomarkers

Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
Bingting Yu, Maikel Peppelenbosch, Gwenny Fuhler

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008422; DOI: 10.1136/jitc-2023-008422
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
Joao V Alessi, Adam Price, Allison L Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief, Federica Pecci, Alessandro Di Federico, Malini M Gandhi, Emily S Lebow, Patricia Mae G Santos, Maria Thor, Andreas Rimner, Adam J Schoenfeld, Jamie E Chaft, Bruce E Johnson, Daniel R Gomez, Mark M Awad, Narek Shaverdian

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007618; DOI: 10.1136/jitc-2023-007618
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, Elena Spirina-Menand, Ronan Flippot, Gaëlle Fromont, Gwenaelle Gravis, Lionnel Geoffrois, Christine Chevreau, Fréderic Rolland, Ellen Blanc, Félix Lefort, Alain Ravaud, Marine Gross-Goupil, Bernard Escudier, Sylvie Negrier, Laurence Albiges

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e006885; DOI: 10.1136/jitc-2023-006885
MDR1-expressing CD4⁺ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response
Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, Christine Ménétrier-Caux

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007733; DOI: 10.1136/jitc-2023-007733
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
Louis Meyblum, Céline Chevaleyre, Sandrine Susini, Benoit Jego, Frederic Deschamps, Dimitri Kereselidze, Baptiste Bonnet, Aurelien Marabelle, Thierry de Baere, Vincent Lebon, Lambros Tselikas, Charles Truillet

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007433; DOI: 10.1136/jitc-2023-007433
CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma
Ruonan Zhang, Jie Wang, Yu Du, Ze Yu, Yihan Wang, Yixiao Jiang, Yixin Wu, Ting Le, Ziqi Li, Guoqiang Zhang, Lei Lv, Haijie Ma

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007529; DOI: 10.1136/jitc-2023-007529
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy
Dingpei Han, Yichao Han, Wei Guo, Wei Wei, Su Yang, Jie Xiang, Jiaming Che, Lianggang Zhu, Junbiao Hang, Tom van den Ende, Hanneke W M van Laarhoven, Bin Li, Youqiong Ye, Hecheng Li

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007847; DOI: 10.1136/jitc-2023-007847
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates
Arabinda Mandal, Jagathpala Shetty, Christine A Tran, Walter C Olson, Mriganka Mandal, Bhupal Ban, Eusebio S Pires, Sara J Adair, Todd W Bauer, Craig L Slingluff, John C Herr

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e008430; DOI: 10.1136/jitc-2023-008430
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e008409; DOI: 10.1136/jitc-2023-008409
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy
Lars Guelen, Thierry O Fischmann, Jerelyn Wong, Smita Mauze, Marco Guadagnoli, Nikolina Bąbała, Jozef Wagenaars, Veronica Juan, David Rosen, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Judith Stammen-Vogelzangs, Ying Yu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Yiwei Zhang, Richard Wnek, Sean Troth, Elliot Chartash, Konstantin Dobrenkov, Svetlana Sadekova, Andrea van Elsas, Jason K Cheung, Laurence Fayadat-Dilman, Jannie Borst, Amy M Beebe, Hans Van Eenennaam

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005049; DOI: 10.1136/jitc-2022-005049

Main menu

tumor biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

tumor biomarkers

Pages